NCT05694065

Brief Summary

Investigating the diagnostic accuracy of online Ultrasonic Flow Ratio (UFR) assessment to identify hemodynamically significant coronary stenosis in patients with suspected ischemic heart disease using angiography-derived fractional flow reserve (FFR) as a reference standard.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Feb 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Feb 2023Dec 2026

First Submitted

Initial submission to the registry

January 12, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 23, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

February 17, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2024

Completed
1 year until next milestone

Results Posted

Study results publicly available

November 24, 2025

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

November 24, 2025

Status Verified

August 1, 2025

Enrollment Period

1.8 years

First QC Date

January 12, 2023

Results QC Date

August 7, 2025

Last Update Submit

November 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Accuracy of Onsite UFR

    UFR was computed as the pressure ratio across a coronary stenosis, using FFR ≤0.80 as the reference standard for hemodynamically significant stenosis. The diagnostic performance of onsite UFR was assessed by the area under the receiver operating characteristic (ROC) curve analysis, with diagnostic accuracy defined as the percentage of all correctly classified cases (true positives and true negatives) in the total population.

    baseline

Secondary Outcomes (4)

  • Sensitivity of Onsite UFR

    baseline

  • Specificity of Onsite UFR

    baseline

  • Sensitivity of Minimal Lumen Area (MLA)

    baseline

  • Specificity of MLA

    baseline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with suspected ischemic heart disease who undergo coronary angiography.

You may qualify if:

  • Subject must be ≥ 18 years
  • Patients suspected with ischemic heart disease
  • ≥ 1 diseased vessel with angiographic percent diameter stenosis between 40% and 80% in a vessel ≥ 2.5mm by visual estimation
  • Target vessels are limited to major epicardial coronary arteries (left anterior descending artery \[LAD\], left circumflex artery \[LCX\], right coronary artery \[RCA\])

You may not qualify if:

  • Patients with previous coronary artery bypass grafting (CABG)
  • Myocardial infarction within 72h of coronary angiography
  • Allergy to the contrast agent or adenosine
  • Left main coronary artery stenosis ≥ 50%
  • Target vessel with in-stent restenosis
  • Target vessel with severe tortuosity or angulation
  • % occlusion of target vessel
  • Target vessel spasm or injury
  • Target vessel with severe myocardial bridge
  • Target vessel with severe thrombosis
  • Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion
  • Presence of false lumen at target vessel based on IVUS
  • A serum creatinine level \>150 umol/l, or a glomerular filtration rate \< 45 ml/kg/1.73 m\^2
  • Heart failure
  • Ineligible for diagnostic intervention (IVUS or FFR examination)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China

Location

MeSH Terms

Conditions

Myocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular Diseases

Results Point of Contact

Title
Dr. Fenghua Ding
Organization
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Study Officials

  • Fenghua Ding, MD, PhD

    Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2023

First Posted

January 23, 2023

Study Start

February 17, 2023

Primary Completion

November 22, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

November 24, 2025

Results First Posted

November 24, 2025

Record last verified: 2025-08

Locations